40 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
payers in the future. As a result of the continuing evaluation and assessment of these expected payments, our estimates for expected payments could … in the assessment of our internal control over financial reporting;
not being required to comply with any requirement that may be adopted by the Public Company
8-K
EX-10.1
yhyklqgi04
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K/A
EX-99.1
krm3ydvkku1buz1xweq
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
EX-10.1
au96kc1mpz
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
s102db4s97 6h736s52m
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
425
mamez
10 Jul 23
Business combination disclosure
8:03am
8-K
EX-10.1
nkix8y
10 Jul 23
Entry into a Material Definitive Agreement
8:00am
424B3
ch16q
23 Jun 23
Prospectus supplement
4:47pm